ExodusPoint Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-18,691
| Closed | -$364K | – | 1754 |
|
|
2024
Q3 | $364K | Buy |
+18,691
| New | +$364K | ﹤0.01% | 1204 |
|
|
2023
Q1 | – | Sell |
-32,833
| Closed | -$1.11M | – | 1912 |
|
|
2022
Q4 | $1.11M | Buy |
32,833
+30,763
| +1,486% | +$1.04M | 0.02% | 872 |
|
|
2022
Q3 | $99K | Buy |
+2,070
| New | +$99K | ﹤0.01% | 1713 |
|
|
2022
Q2 | – | Sell |
-27,714
| Closed | -$2.24M | – | 2205 |
|
|
2022
Q1 | $2.24M | Buy |
27,714
+26,322
| +1,891% | +$2.13M | 0.03% | 670 |
|
|
2021
Q4 | $282K | Sell |
1,392
-2,392
| -63% | -$485K | ﹤0.01% | 1648 |
|
|
2021
Q3 | $1.02M | Buy |
3,784
+920
| +32% | +$248K | 0.01% | 972 |
|
|
2021
Q2 | $737K | Buy |
+2,864
| New | +$737K | 0.01% | 1094 |
|
|
2021
Q1 | – | Sell |
-1,103
| Closed | -$281K | – | 2375 |
|
|
2020
Q4 | $281K | Sell |
1,103
-2,264
| -67% | -$577K | ﹤0.01% | 1503 |
|
|
2020
Q3 | $838K | Buy |
3,367
+996
| +42% | +$248K | 0.02% | 710 |
|
|
2020
Q2 | $824K | Buy |
+2,371
| New | +$824K | 0.02% | 818 |
|
|
2020
Q1 | – | Sell |
-2,752
| Closed | -$891K | – | 1410 |
|
|
2019
Q4 | $891K | Buy |
+2,752
| New | +$891K | 0.02% | 549 |
|